Dayatan, Jenalyn .

HRN: 27-73-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
CEFUROXIME 1.5GM (VIAL)
10/11/2025
10/11/2025
IV
1500mg
On Call To OR
For Dilation And Curettage
Waiting Final Action 
10/12/2025
CEFUROXIME 500MG (TAB)
10/12/2025
10/18/2025
ORAL
500mg
2 Times A Day
S/P Diagnostic Curettage And Cervical Punch Biopsy
Checking Final Appropriateness 
10/12/2025
CEFUROXIME 1.5GM (VIAL)
10/12/2025
10/13/2025
IV
1.5 Grams
Every 8 Hours
S/P Diagnostic Curettage And Cervical Punch Biopsy
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: